DNA intercalator stimulates influenza transcription and virus replication
© Li and Poon; licensee BioMed Central Ltd. 2011
Received: 1 February 2011
Accepted: 15 March 2011
Published: 15 March 2011
Influenza A virus uses its host transcription machinery to facilitate viral RNA synthesis, an event that is associated with cellular RNA polymerase II (RNAPII). In this study, various RNAPII transcription inhibitors were used to investigate the effect of RNAPII phosphorylation status on viral RNA transcription. A low concentration of DNA intercalators, such as actinomycin D (ActD), was found to stimulate viral polymerase activity and virus replication. This effect was not observed in cells treated with RNAPII kinase inhibitors. In addition, the loss of RNAPIIa in infected cells was due to the shift of nonphosphorylated RNAPII (RNAPIIa) to hyperphosphorylated RNAPII (RNAPIIo).
The C-terminal domain (CTD) of RNAPII is important for cellular mRNA transcription, and interacts with several post-transcriptional factors for RNA maturation and nuclear export. The phosphorylation status of CTD is known to be a critical regulatory checkpoint for RNAPII transcription . The hyperphosphorylated (transcriptionally engaged) form of RNAPII is designated as RNAPIIo, whereas its nonphosphorylated (transcriptionally inactive) form is designated as RNAPIIa. At the early stage of transcription, free RNAPIIa interacts with other general transcription factors on cellular DNA promoters to form a transcription pre-initiation complex, which is followed by transcription initiation . The newly initiated RNAPIIa then proceeds to the promoter-proximal pause region, and the paused RNAPIIa is subsequently hyperphosphorylated, preferably on the serine 5 (Ser5) positions, by cyclin-dependent kinase (Cdk) 7. As transcription elongation proceeds, the serine 2 (Ser2) and Ser5 positions in the CTD of RNAPII are hyperphosphorylated by Cdk9  and dephosphorylated by SCP1 , respectively. The Ser5-phosphorylation helps to recruit enzymes to cap the nascent RNA transcript, whereas the Ser2-phosphorylation facilitates the conversion of RNAPII into a productive elongating form.
Influenza viral RNA synthesis is dependent on its host transcription machinery. Various RNAPII inhibitors such as α-amantin and actinomycin D (ActD) have been shown to inhibit influenza virus replication [5–7]. Chan et al. demonstrated that the influenza viral polymerase complex can inhibit RNAPII transcription elongation, but not initiation , a phenomenon that is similar to the transcriptional arrest of RNAPII. This transcriptional arrest may be related to direct interaction between vRNP and Ser5-phosphorylated RNAPIIo . It has also been demonstrated that a robust polymerase complex is more capable of binding to RNAPIIo . Recently, influenza viral polymerase has been proposed to induce the direct degradation of RNAPIIa [11–13], thereby inhibiting host gene expression. The overall conclusion of these previous findings is that RNAPII plays a critical role in viral RNA transcription, although little is known about the mechanism responsible for RNAPIIa disappearance during infection. Moreover, the role played by the post-translation modification of RNAPII in viral RNA synthesis is yet to be determined. In this study, we would like to determine the effect of various RNAPII inhibitors on influenza viral polymerase functions and virus replications. In particular, the inhibitors used in this study are known to inhibit RNAPII via different mechanisms and have different effects on the phosphorylation status of RNAPII. It is of our interest to use these chemicals to understand how the influenza virus can utilize RNAPII to facilitate viral RNA synthesis.
Influenza A virus infection results in a significant loss of transcriptionally inactive RNAPII (RNAPIIa) [11–13]. However, as influenza polymerase requires capped primers snatched from the host nuclear RNA for its viral RNA transcription [20–22], a direct induction of RNAPIIa degradation via the viral polymerase may not favour such a transcription. In this study, it has been demonstrated here that the disappearance of RNAPIIa is related to a shift of RNAPIIa to RNAPIIo (Figure 3). In addition, this conversion of RNAPIIa to RNAPIIo is found to be important to viral RNA synthesis, which suggests that newly synthesized RNAPIIo may be a critical determinant of viral transcription. RNAPII can be subjected to various post-translational modifications . Further investigation of the post-translational modification of RNAPII in influenza virus-infected cells may help us to better understand the transcription and replication of influenza viruses.
This project is supported by National Institutes of Health (NIAID contract HHSN266200700005C, LLM), Research Grant Council of Hong Kong (HKU 7530/06M, LLM), Area of Excellence Scheme of the University Grants Committee (Grant AoE/M-12/06). We thank George Brownlee for plasmids, Ervin Fodor and Hui-Ling Yen for critical comments.
- Egloff S, Murphy S: Cracking the RNA polymerase II CTD code. Trends Genet. 2008, 24: 280-288. 10.1016/j.tig.2008.03.008.View ArticlePubMed
- Fuda NJ, Ardehali MB, Lis JT: Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature. 2009, 461: 186-192. 10.1038/nature08449.PubMed CentralView ArticlePubMed
- Palancade B, Bensaude O: Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur J Biochem. 2003, 270: 3859-3870. 10.1046/j.1432-1033.2003.03794.x.View ArticlePubMed
- Zhang Y, Kim Y, Genoud N, Gao J, Kelly JW, Pfaff SL, Gill GN, Dixon JE, Noel JP: Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. Mol Cell. 2006, 24: 759-770. 10.1016/j.molcel.2006.10.027.PubMed CentralView ArticlePubMed
- Kurokawa M, Ochiai H, Nakajima K, Niwayama S: Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus. J Gen Virol. 1990, 71 (Pt 9): 2149-2155. 10.1099/0022-1317-71-9-2149.View ArticlePubMed
- Minor PD, Dimmock NJ: Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function. Virology. 1977, 78: 393-406. 10.1016/0042-6822(77)90116-7.View ArticlePubMed
- Nguyen VT, Giannoni F, Dubois MF, Seo SJ, Vigneron M, Kedinger C, Bensaude O: In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res. 1996, 24: 2924-2929. 10.1093/nar/24.15.2924.PubMed CentralView ArticlePubMed
- Chan AY, Vreede FT, Smith M, Engelhardt OG, Fodor E: Influenza virus inhibits RNA polymerase II elongation. Virology. 2006, 351: 210-217. 10.1016/j.virol.2006.03.005.View ArticlePubMed
- Engelhardt OG, Smith M, Fodor E: Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol. 2005, 79: 5812-5818. 10.1128/JVI.79.9.5812-5818.2005.PubMed CentralView ArticlePubMed
- Li OT, Chan MC, Leung CS, Chan RW, Guan Y, Nicholls JM, Poon LL: Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One. 2009, 4: e5658-10.1371/journal.pone.0005658.PubMed CentralView ArticlePubMed
- Rodriguez A, Perez-Gonzalez A, Nieto A: Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol. 2007, 81: 5315-5324. 10.1128/JVI.02129-06.PubMed CentralView ArticlePubMed
- Rodriguez A, Perez-Gonzalez A, Hossain MJ, Chen LM, Rolling T, Perez-Brena P, Donis R, Kochs G, Nieto A: Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. J Virol. 2009, 83: 11166-11174. 10.1128/JVI.01439-09.PubMed CentralView ArticlePubMed
- Vreede FT, Chan AY, Sharps J, Fodor E: Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology. 2010, 396: 125-134. 10.1016/j.virol.2009.10.003.PubMed CentralView ArticlePubMed
- Bensaude O, Bonnet F, Casse C, Dubois MF, Nguyen VT, Palancade B: Regulated phosphorylation of the RNA polymerase II C-terminal domain (CTD). Biochem Cell Biol. 1999, 77: 249-255. 10.1139/bcb-77-4-249.View ArticlePubMed
- Casse C, Giannoni F, Nguyen VT, Dubois MF, Bensaude O: The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase II C-terminal domain. J Biol Chem. 1999, 274: 16097-16106. 10.1074/jbc.274.23.16097.View ArticlePubMed
- Fromaget M, Cook PR: Photobleaching reveals complex effects of inhibitors on transcribing RNA polymerase II in living cells. Exp Cell Res. 2007, 313: 3026-3033. 10.1016/j.yexcr.2007.04.036.View ArticlePubMed
- Mark GE, Taylor JM, Broni B, Krug RM: Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin. J Virol. 1979, 29: 744-752.PubMed CentralPubMed
- Kimura H, Sugaya K, Cook PR: The transcription cycle of RNA polymerase II in living cells. J Cell Biol. 2002, 159: 777-782. 10.1083/jcb.200206019.PubMed CentralView ArticlePubMed
- Dubois MF, Nguyen VT, Bellier S, Bensaude O: Inhibitors of transcription such as 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J Biol Chem. 1994, 269: 13331-13336.PubMed
- Bouloy M, Morgan MA, Shatkin AJ, Krug RM: Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol. 1979, 32: 895-904.PubMed CentralPubMed
- Plotch SJ, Bouloy M, Krug RM: Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci USA. 1979, 76: 1618-1622. 10.1073/pnas.76.4.1618.PubMed CentralView ArticlePubMed
- Plotch SJ, Tomasz J, Krug RM: Absence of detectable capping and methylating enzymes in influenza virions. J Virol. 1978, 28: 75-83.PubMed CentralPubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.